What's breaking now, across thousands of outlets.
Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths to get their hands on unregulated versions. Stephanie Sy reports for our series, GLP-1s: Reshaping America.
We haven't written up this one. PBS NewsHour Health has the full story — the link below goes straight to it.
In the first weeks after the Oct. 7 attack, distress was widespread. But for many, the psychological consequences of the war did not unfold separately from another growing source of pressure: money.
This GEN webinar follows oligo quantification from method development through conjugate characterization. The post Lock Down the Critical Factors in Oligo and Oligo-Conjugate Characterization with…
The Trump administration told a federal appeals panel Tuesday that a lower court erred in blocking Health Secretary Robert F.
Not all protein is created equally.
Click in for more news from The Hill {beacon} Healthcare Healthcare The Big Story HHS revamps price transparency rules The Trump administration is revamping its transparency rules, trying to make…
Sylvester Ojenagbon Walk into almost any home after a heavy rain, and you will encounter it somewhere. It could be a dark patch behind the wardrobe, a grey bloom along the bathroom ceiling, or a musty…
